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Abstract
Longitudinal monitoring of cells is required in order to understand the role of delivered stem cells in therapeutic
neovascularization. However, there is not an imaging technique that is capable of quantitative, longitudinal assessment of
stem cell behaviors with high spatial resolution and sufficient penetration depth. In this study, in vivo and in vitro
experiments were performed to demonstrate the efficacy of ultrasound-guided photoacoustic (US/PA) imaging to monitor
mesenchymal stem cells (MSCs) labeled with gold nanotracers (Au NTs). The Au NT labeled MSCs, injected intramuscularly in
the lower limb of the Lewis rat, were detected and spatially resolved. Furthermore, our quantitative in vitro cell studies
indicate that US/PA imaging is capable of high detection sensitivity (1610
4 cells/mL) of the Au NT labeled MSCs. Finally, Au
NT labeled MSCs captured in the PEGylated fibrin gel system were imaged in vivo, as well as in vitro, over a one week time
period, suggesting that longitudinal cell tracking using US/PA imaging is possible. Overall, Au NT labeling of MSCs and US/
PA imaging can be an alternative approach in stem cell imaging capable of noninvasive, sensitive, quantitative, longitudinal
assessment of stem cell behaviors with high spatial and temporal resolutions at sufficient depths.
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Introduction
Ischemic heart disease is one of the most common killers of
American men and women, accounting for about half a million
deaths every year [1,2]. Recent experimental and preclinical
research suggests that stem cell therapy can be a safe and clinically
feasible alternative treatment for ischemic heart disease because
stem cells can differentiate into multiple cell types, including
vascular cells contributing to myocardial regeneration [3,4]. It was
previously demonstrated that tubulogenesis and differentiation of
mesenchymal stem cells (MSCs) to vascular cell phenotypes can be
enhanced within tissue-engineered matrices, indicating the possi-
bility of stem cell delivery to ischemic regions to promote
neovascularization [5–8]. In order to obtain a better understand-
ing of the role of stem cells in neovascularization, continuous
monitoring of the distribution of stem cells, as well as interaction of
the stem cells with their microenvironment, is essential. Therefore,
there is a need for a stem cell imaging technique that is not only
noninvasive and sensitive, but also capable of quantitative,
longitudinal assessment of stem cell behaviors with high spatial
resolution.
Unfortunately, none of the current stem cell imaging modalities
can satisfy all requirements simultaneously. Magnetic resonance
imaging (MRI), with contrast agents based on superparamagnetic
iron oxide, has been widely researched for stem cell monitoring.
Although MRI can achieve relatively high resolution and long-
term cell tracking, it has low sensitivity with the current contrast
agents [9–12]. Radioactive imaging, including single photon
emission computed tomography (SPECT) and positron emission
tomography (PET), has a fair sensitivity with direct labeling of
stem cells. However, high spatial resolution and long-term imaging
are not obtainable with SPECT and PET due to intrinsic
limitations, such as the short half-lives of radioisotopes [9–12].
While direct cell labeling with MRI and radioactive imaging
cannot provide information about cell proliferation, reporter gene
labeling is capable of tracking cell division with radioactive and
optical imaging techniques. Yet, imaging with reporter gene
labeling is still limited for clinical approaches due to cell safety
issues, such as immunogenic responses and transfection [9–12].
Optical imaging modalities, including fluorescence and biolumi-
nescence imaging, have the highest sensitivity and highest
resolution among the available imaging methods, but they are
restricted by shallow penetration depth and phototoxicity, thus
limiting the clinical applicability [9,13].
In this study, we explored the feasibility of imaging stem cells
using ultrasound-guided photoacoustic (US/PA) imaging [14–18].
In photoacoustic imaging, a photoacoustic wave is generated by
thermal expansion of tissue after absorption of a short laser pulse.
The magnitude of the photoacoustic wave is proportional to the
laser fluence and to the optical absorption coefficient. Similar to
ultrasound, photoacoustic imaging provides a penetration depth of
several centimeters and sub-millimeter spatial resolution [19–21].
In addition, similarities between photoacoustic and ultrasound
imaging systems enable the hybrid implementation of the two
modalities, thus providing synergetic benefits, such as the
capability of visualizing morphological, functional, and molecular
properties [22]. Thus, the US/PA imaging method may have
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and neovascularization promoted by MSCs [23,24].
Unfortunately, MSCs do not have sufficient optical absorption
and cannot be directly visualized using US/PA imaging. However,
as depicted in Figure 1, the optical properties of MSCs can be
altered by labeling MSCs with gold nanotracers (Au NTs) and
using US/PA imaging to monitor and track the cells. Therefore, in
this study, in vivo as well as in vitro experiments were performed to
evaluate in vivo detectability, sensitivity, quantification, and long-
term MSC tracking ability with the suggested method. To
demonstrate the feasibility of noninvasive monitoring of MSCs
labeled with Au NTs, in vivo US/PA imaging of the nanotracer
labeled MSCs injected intramuscularly in the lower limb of the rat
was conducted. Following in vivo studies, sensitivity as well as
quantification of the ultrasound and photoacoustic imaging
method were assessed using a tissue mimicking gelatin phantom
with inclusions of Au NT labeled and non-labeled MSCs.
Furthermore, Au NT labeled MSCs cultured in vitro in a
PEGylated fibrin gel system were imaged over a one week time
period to verify the possibility of longitudinal cell tracking using
photoacoustic imaging. Finally, longitudinal in vivo monitoring of
spatial distribution of the PEGylated fibrin gel containing the Au
NT labeled MSCs was demonstrated at the three different time
points (day 3, 7, and 10 after the injection).
Results
Au NT labeling of MSCs
Gold nanoparticles are one of the most widely used nanotracers
for imaging cells of various types due to their excellent
biocompatibility, as well as tunable optical properties [25–27]. It
was recently demonstrated that gold nanoparticles can be safe and
effective nanotracers for longitudinal tracking of MSCs [28].
Specifically, cell viability, cell proliferation, and cell differentiation
were not significantly affected by nanotracer uptake of various
sizes and surface coatings [28]. For this study, MSCs were labeled
with 20 nm Au NTs (Figure 2A), which were prepared and used as
previously described [28]. MSCs were incubated with cell culture
medium including Au NTs for 24 hours while control cells were
not. After MSC culture with nanotracer solutions, darkfield images
(Figure 2B and Figure 2C) were obtained to assess nanotracer
uptake. While the non-labeled MSCs in Figure 2B appear bluish,
Figure 2C shows orange colored nanotracers which endocytosed
in the MSCs. Furthermore, as shown in Figure 2D and Figure 2F,
passive loading of Au NTs to MSCs resulted in a red-shift and
peak broadening in their absorbance spectrum due to nanoparticle
aggregation inside the cells [28,29]. In addition, inductively
coupled plasma mass spectrometry (ICP-MS) was used to quantify
nanotracer loading in the cells. It was found that the average
nanotracer loading was [4.5360.04]610
5 nanotracers per MSC.
In vivo monitoring of Au NT labeled MSCs using
ultrasound and photoacoustic imaging
The unique optical properties of Au NT labeled MSCs with a
broad range of wavelengths, including in the near-infrared (NIR)
optical window in biological tissue, allow noninvasive photo-
acoustic imaging as well as spectral analysis to distinguish MSCs
from background tissue (Figure S1A). To demonstrate the
feasibility of noninvasive in vivo monitoring of MSCs, the Au NT
labeled MSCs were injected intramuscularly in the hind limb of
the rat and visualized using US/PA imaging. A PEGylated fibrin
gel with Au NT loaded MSCs (1610
5 cells/mL) was injected
intramuscularly in the lateral gastrocnemius (LGAS) of an
anesthetized Lewis rat and immediately imaged at a range of
Figure 1. Diagram of the procedure for monitoring mesenchy-
mal stem cells (MSCs) in vivo. Once MSCs are loaded with nano-
tracers, the labeled MSCs are entrapped in the PEGylated fibrin gels and
implanted at the ischemic region. The PEGylated fibrin gels promote
MSC differentiation toward a vascular cell type, thus contributing to
regeneration. Both MSC distribution and neovascularization can be
monitored using the combined ultrasound and photoacoustic imaging
of cells loaded with nanotracer such as gold plasmonic nanoparticles.
doi:10.1371/journal.pone.0037267.g001
In vivo US/PA Monitoring of MSCs/Au NTs
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cm
2, which was verified to be safe (Figure S2) and lower than the
maximum allowable laser fluence [30]. In addition, a region of the
LGAS of the other hind limb without any injection served as a
control. Figures 3A, 3B, 3C, 3D represent ultrasound, photo-
acoustic, US/PA, and US/spectroscopic images, respectively, of
the LGAS in which PEGylated fibrin with Au NT loaded MSCs
was injected. The ultrasound image shows the structural informa-
tion of the lower limb, but the location of MSCs cannot be
identified. However, the photoacoustic and US/PA images clearly
show the location of the nanotracer signal from MSCs in the gel
outlined in yellow. In order to distinguish the photoacoustic signal
from the Au NT labeled MSCs from surrounding tissue, spectral
analysis can be performed, which augments photoacoustic
imaging. Specifically, the unique absorbance of Au NT labeled
MSCs compared with those of oxygenated and deoxygenated
hemoglobin (Figure S1A) can be accurately detected using
multiwavelength photoacoustic imaging (Figure S1B). Therefore,
as shown in Figure 3D, the Au NT labeled MSCs (shown in green)
can be clearly distinguished from other tissue constituents, such as
oxygenated (red) hemoglobin, deoxygenated (blue) hemoglobin,
and skin (yellow), by spectral analysis. As shown in Figures 3E, 3F,
3G, 3H of the control, photoacoustic signals were generated only
from the background tissue (mainly skin and blood). This result
indicates that US/PA imaging has the capability of monitoring
MSCs labeled with nanotracers noninvasively.
Quantification of Au NT labeled MSCs
In addition to the in vivo detectability of the Au NT labeled stem
cells, accurate quantification of stem cells with high sensitivity is
one of the essential requirements for effective stem cell tracking
methods. To evaluate the sensitivity and cell quantification ability
of photoacoustic imaging, an in vitro experiment using a tissue
mimicking gelatin phantom was performed. Figure 4A shows the
ultrasound, photoacoustic, and US/PA images of the tissue
mimicking phantom with inclusions containing Au NT labeled
Figure 2. Gold nanotracer (Au NT) labeling of MSCs. (A) The TEM image of 20 nm gold nanotracers and the dark field images (206
magnification) of MSCs without and with nanotracer loading (B and C, respectively). The normalized absorbance spectra of Au NTs, MSCs and the Au
NT labeled MSCs (D,E, and F, respectively).
doi:10.1371/journal.pone.0037267.g002
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signals were not detected from any of the inclusions with the non-
labeled MSCs, regardless of the concentration of MSCs, because
the cells themselves do not absorb light. Furthermore, the
quantitative analysis of the photoacoustic signal amplitudes
measured from the Au NT labeled inclusions, using a laser
fluence of 5.1 mJ/cm
2, is shown in Figure 4B. The means and
standard deviations of the photoacoustic signal amplitudes were
calculated from twelve subareas (0.4 mm60.77 mm) in the Au NT
labeled MSC inclusions as shown in the outer graph of Figure 4B
on a semi-logarithmic scale. The inset graph presents the linear
regression fit (with an R
2 value of 0.984) of the mean values of the
photoacoustic signal amplitudes as a function of the nanotracer
concentration on a linear scale. The results indicate that the
amplitude of the photoacoustic signal is proportional to the
concentration of optical absorbers, which are the Au NTs loaded
inside MSCs. The results also indicate that with a fluence of
5.1 mJ/cm
2, a photoacoustic signal can be detected for a
nanotracer concentration as low as 4.53610
9 NTs/mL, which
corresponds to 1610
4 cells/mL and 200 cells. Therefore, the
Figure 3. In vivo monitoring of Au NT labeled MSCs using combined ultrasound and photoacoustic (US/PA) imaging. (A–D) In vivo
ultrasound, photoacoustic, US/PA, and US/spectroscopic images of the LGAS in which PEGylated fibrin gel containing Au NT loaded MSCs (1610
5
cells/mL) was injected. PEGylated fibrin gel location is outlined with yellow dotted circle. Injection depth was about 5 mm under the skin. (E–H)
Control at the region of the LGAS of the other hind limb without any injection. Photoacoustic images were acquired at the wavelength of 760 nm
with a fluence of 11 mJ/cm
2. Spectral (650–920 nm) analysis of photoacoustic signal was able to differentiate skin (shown in yellow), oxygenated
(red) and deoxygenated (blue) blood, and Au NT loaded MSCs (green). The images measure 23 mm laterally and 12.5 mm axially.
doi:10.1371/journal.pone.0037267.g003
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concentrations with excellent sensitivity better than other nonin-
vasive stem cell tracking methods [20,31].
Longitudinal in vitro photoacoustic imaging of MSCs
labeled with Au NTs
Although we can achieve high sensitivity and cell quantification
ability using the photoacoustic imaging, continuous cell tracking is
essential to monitor MSC migration and proliferation. To
demonstrate this, longitudinal (up to 7 days) photoacoustic images
of MSCs loaded with Au NTs, or MSCs only, in PEGylated fibrin
gels were acquired at a wavelength of 750 nm with a fluence of
11 mJ/cm
2 (Figure 5A). The PEGylated fibrin gels were cast as
previously described [5,6], and MSCs were entrapped into the
PEGylated fibrin gels at a concentration of 5610
4 cells/mL. The
MSCs were cultured in the PEGylated fibrin gels in a 24 well plate
over a one week period and imaged at three different time points
(day 1, 4, and 7). As shown in Figure 5A, while the MSCs without
Au NT loading did not produce any photoacoustic signal, strong
photoacoustic signals were detected from the MSCs loaded with
Au NTs over a one week time period. As we previously evaluated,
nanoparticle loading decreased exponentially over time due to
both cell division and exocytosis of the nanoparticles by the cells
[28]. The photoacoustic signals from the PEGylated fibrin gels
were quantitatively analyzed as shown in Figure 5B. Specifically,
the means and standard deviations of the photoacoustic signal
amplitudes obtained from nine subareas (2 mm62m m 62 mm) in
the PEGylated fibrin gels containing the MSCs with and without
Au NT loading were shown in red and orange colors in Figure 5B,
respectively. Because the photoacoustic signal is proportional to
the concentration of Au NTs as demonstrated above, the Au NT
concentration at three different time points could be quantified to
[2.2760.31]610
10 NTs/mL, [1.7160.27]610
10 NTs/mL, and
[1.3760.18]610
10 NTs/mL for day 1, 4, and 7, respectively.
Furthermore, sensitivity of the photoacoustic imaging was enough
to detect the labeled MSCs in spite of the decrease in Au NT
loading. Hence, this result implies that photoacoustic imaging can
be used to assess temporal behaviors of the Au NT labeled MSCs.
Longitudinal in vivo monitoring of the spatial
distribution of MSCs labeled with Au NTs using US/PS
imaging
Based on the longitudinal in vitro study, the Au NT labeled
MSCs were longitudinally monitored in vivo. After injection of the
PEGylated fibrin gel with Au NT loaded MSCs (5610
4 cells/mL,
300 mL) into the LGAS of the Lewis rat, the labeled MSCs were
imaged at the three different time points (day 3, 7, and 10) using
the ultrasound guided spectroscopic imaging. As demonstrated
above, spectral analysis of the photoacoustic signals acquired at a
range of wavelengths from 650 nm to 920 nm differentiated the
Au NT labeled MSCs from other tissue components. Figure 6A
shows 3-D combined ultrasound and spectroscopic images of the
Figure 4. Quantification of Au NT labeled MSCs. (A) Ultrasound (top), photoacoustic (middle), and US/PA images (bottom) of the gelatin
phantom with inclusions containing different concentrations of MSCs. Photoacoustic images were obtained at a wavelength of 750 nm with a
fluence of 5.1 mJ/cm
2. All images measure 98 mm laterally and 7.7 mm axially. (B) The quantitative analysis of photoacoustic signal. The mean and
the standard deviation of the photoacoustic signal amplitude as a function of the nanoparticle concentration is shown in the outer graph in a semi-
logarithmic scale. The inset graph presents the linear regression fit (with an R
2 value of 0.984) of the mean values of the photoacoustic signal
amplitude as a function of the nanoparticle concentration in a linear scale.
doi:10.1371/journal.pone.0037267.g004
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the MSCs labeled with Au NTs, presented in green color, could be
monitored for 10 days after the injection. Figure 6B shows
quantitative analysis of the longitudinal in vivo imaging result. The
photoacoustic signals obtained from the spatial positions of the
labeled MSCs determined by the spectral analysis were summed
and displayed in green color in the graph. Moreover, the
photoacoustic signals from the background tissue were also
analyzed and added to the graph with yellow color for the
control. The Au NT concentration at day 3, 7, and 10 were able to
be quantified to 2.27610
10 NTs/mL, 2.06610
10 NTs/mL, and
1.59610
10 NTs/mL respectively. Furthermore, this result also
implies that the Au NT labeled MSCs can be detected if
photoacoustic signals from the labeled cells are reasonably
stronger than those from the background tissue, which are
equivalent to [2.1160.37]610
3 MSCs and [3.1865.56]610
9
NTs/mL. Therefore, noninvasive in vivo longitudinal monitoring
of MSCs labeled with nanotracers is capable with quantification
and high sensitivity using US/PA imaging.
Discussion
The results of this study demonstrate the feasibility of
longitudinal in vivo monitoring of MSCs labeled with nano-
tracers. Once Au NT labeled MSCs are implanted into tissue,
photoacoustic imaging can noninvasively detect the presence
of MSCs with sufficient penetration depth (,10–50 mm) and
spatial resolution (,20–300 mm), which are scalable depend-
ing on the specification of the transducer, such as the center
frequency [21,32]. Furthermore, Au NT labeled MSCs are
able to be monitored with high sensitivity (,10
2–10
3 cells) and
good cell viability over a long-term period (,2 weeks), as de-
monstrated with our in vitro and in vivo photoacoustic imaging
results with the PEGylated fibrin gel system. As mentioned in
the introduction of this paper, other stem cell imaging moda-
lities have their own drawbacks, such as sensitivity and spatial
resolution (MRI), safety and tracking period (PET and
SPECT), and penetration depth (optical microscopy) [9–
13,31,33]. However, US/PA imagin gu s i n gA uN Tl a b e l i n go f
MSCs can achieve various advantages simultaneously (safety,
longitudinal imaging, ability to track cell distribution, high
sensitivity, and high spatial resolution). Therefore, the
nanotracer augmented ultrasound guided photoacoustic im-
aging of stem cells can be an alternative way to move beyond
limitations of current stem cell imaging modalities.
In addition to monitoring the spatial distribution of the
stem cells, neovascularization promoted from stem cells
needs to be monitored to estimate the efficacy of the stem cell
treatment. However, this work was an initial study to
demonstrate the feasibility of longitudinal in vivo tracking
using US/PA imaging. Our in vivo work consisted of animals
which did not undergo any injury (e.g. femoral ligation), and
thus neovascularization was not sufficiently promoted
because the PEGylated fibrin gels with MSCs were injected
into normal muscles. However, based on our previous
research, we believe that the PEGylated fibrin can promote
neovascularization in an ischemic muscle due to the upre-
gulation of certain growth factors and paracrine signals as a
result of the wound healing response [5–8]. Furthermore,
using multiwavelength photoacoustic imaging, micro-blood
vessels can be noninvasively imaged and quantitatively
assessed without exogenous contrast agents [23,24]. There-
fore, using this technique, neovascularization developed from
the implanted MSCs can be continuously monitored and
distinguished from background tissue with morphological
information obtained by ultrasound imaging.
US/PA imaging can be a valuable tool for tissue engineering
because it allows noninvasive and longitudinal tracking of MSCs
with penetration depths up to several centimeters and reasonable
spatial resolution. While optical imaging is widely being used in
the tissue engineering field, such as fluorescence and multiphoton
imaging, it suffers from limited penetration depth (,0.5 mm) and
photobleaching [21,32]. In contrast, the current technique
provides experimentally and statistically consistent results from a
Figure 5. Longitudinal in vitro photoacoustic imaging of MSCs labeled with Au NTs. (A) Longitudinal photoacoustic images of MSCs loaded
with Au NTs, or MSCs only, in a PEGylated fibrin gel at a wavelength of 750 nm with a fluence of 11 mJ/cm
2. The MSCs in the PEGylated fibrin gel
were cultured in a 24 well plate over a one week time period. While the MSCs without Au NT loading did not produce any photoacoustic signal,
strong photoacoustic signals were detected from the MSCs loaded with Au NTs over a one week time period. The images measure 14.1 mm laterally
and 16.6 mm axially. (B) The quantitative analysis of photoacoustic signal. The mean and the standard deviation of the photoacoustic signal
amplitude from the PEGylated fibrin gels containing the MSCs with and without Au NT loading were shown in green and yellow colors, respectively.
doi:10.1371/journal.pone.0037267.g005
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imaging can be a promising alternative for visualizing and tracking
MSCs within tissue engineered constructs.
In conclusion, the presented work demonstrates the ability of
the US/PA imaging to noninvasively monitor MSCs labeled with
Au NTs. Au NT labeled MSCs injected intramuscularly in the
lower limb of the Lewis rat were capable of being visualized using
in vivo US/PA imaging, which indicates the ability of noninvasive
monitoring of MSCs. Furthermore, the Au NT labeled MSCs
were identified with high detection sensitivity in vitro (4.53610
9
NTs/mL corresponding to 1610
4 cells/mL and 200 cells) using
ultrasound and photoacoustic imaging. In addition, Au NT
labeled MSCs captured in the PEGylated fibrin gel system were
able to be imaged in vivo, as well as in vitro, over a one week time
period, which implies the possibility of longitudinal cell tracking
using photoacoustic imaging. Accordingly, US/PA imaging using
Au NT labeling of MSCs has great potential to be an alternative
imaging method to monitor stem cell distribution and better
understand the process of neovasularization and the wound
healing response. Future work for this study includes in vivo
monitoring of long-term MSC behaviors following an injury in
order to assess and monitor the participation of MSCs in the
process of neovascularization.
Materials and Methods
Au NT labeling of MSCs
Gold nanotracers, which are 20 nm gold nanospheres, were
synthesized via citrate reduction of tetrachloroauric (III) acid
(HAuCl4) under reflux, as described elsewhere [28]. Gold
nanotracer (Au NT) cell culture medium was made by centrifuging
the nanotracer solutions (50006g for 15 minutes) and resuspend-
ing the pellet in phenol red free cell culture medium. The Au NT
medium was added to the cell culture and allowed to incubate with
mesenchymal stem cells (MSCs; Lonza, Walkersville, MD) for
24 hours. After 24 hours, the nanotracer medium was removed
and the cells were washed with phosphate-buffered saline (PBS).
Control cells were not incubated with Au NT cell culture medium.
Nanotracer uptake was assessed using darkfield microscopy (Leica
DMI2000B microscope equipped with a Leica DFC290 camera).
Preparation of the PEGylated fibrin gel with Au NT
labeled MSCs
The PEGylated fibrin gels were prepared by adding difunctional
succinimidyl glutarate (SG)-PEG (3400 Da, 8 mg/mL in PBS
without calcium; NOF America) to fibrinogen (80 mg/mL in PBS
without calcium; Sigma) in a 1:1 volume ratio. The reaction was
allowed to take place at room temperature for 3–5 minute. MSCs
Figure 6. Longitudinal in vivo monitoring spatial distribution of MSCs labeled with Au NTs using US/PS imaging. (A) 3-D combined
ultrasound and spectroscopic images of the rat hind limb in which the PEGylated fibrin gel containing Au NT labeled MSCs were injected (day 3,7,
and 10). The MSCs labeled with Au NTs were distinguished using spectral analysis and presented in green color. The bounding box for each image
measures 23 mm laterally, 12.5 mm axially, and 25 mm elevationally. (B) The quantitative analysis of photoacoustic signal. The photoacoustic signals
at three different time points obtained from the Au NT labeled MSCs and the background tissue were summed and displayed in green and yellow
colors, respectively.
doi:10.1371/journal.pone.0037267.g006
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5 cells/mL) were combined with the PEGylated fibrinogen
mixture in a 1:1 volume ratio. The reaction underwent gelation by
adding an equal volume solution of thrombin (25 U/mL in
40 mM CaCl2; CalBiochem). The unbound free PEG was rinsed.
The final concentrations in the gel were 10 mg/mL fibrinogen;
1 mg/mL of SG-PEG; 5610
4 cells/mL; and 12.5 U/mL of
thrombin. The gels were then incubated at 37uC in MSC growth
medium.
Injection of the PEGylated fibrin gel with Au NT labeled
MSCs
Animal handling and care followed the recommendations of the
National Institutes of Health (NIH) guidelines for the care and use
of laboratory animals. All protocols were approved by the Animal
Care Committee of the University of Texas at Austin. Lewis rats
(11 weeks old) weighing 200–250 g were used for the intramus-
cular injection and subsequent US/PA imaging. PEGylated fibrin
injections were prepared by combining fibrinogen (40 mg/mL)
and difunctional SG-PEG (4 mg/mL) in a 1:1 volume ratio and
allowing the reaction to take place at 37uC for 20 minutes. An
equal volume of MSCs labeled with Au NTs were mixed with the
PEGylated fibrin solution in a 1:1 volume ratio at a concentration
of 5610
5 cells/mL. Thrombin (25 U/mL in 40 mM CaCl2) was
loaded into a 23 G needle. An equal volume of the PEGylated
fibrin solution containing cells was then loaded into the syringe
and the solution was mixed within the syringe by shaking the
syringe. The final concentration of the PEGylated fibrin gel
injection was 10 mg/mL fibrinogen; 1 mg/mL SG-PEG; 1610
5
cells/mL; and 12.5 U/mL thrombin. A total volume of 300 mL
was injected in the lateral gastrocnemius of the rat. Injection depth
was about 5 mm under the skin. Prior to the injection, the rat was
anesthetized using 0.5–2.0% isoflurane with 1 L/min of oxygen
and the hind limb of the rat was shaved.
Tissue mimicking phantom with non-labeled and Au NT
labeled MSC inclusions
The tissue mimicking phantom with non-labeled or labeled
MSC inclusions was prepared for combined ultrasound and
photoacoustic (US/PA) imaging. The bottom layer of the
phantom was composed of gelatin (Sigma, 8% by weight) with
15 mm diameter silica particles (Sigma, 0.2% by weight) for
ultrasonic scattering. The eight inclusions (20 mL each) were
placed on top of the bottom layer and were composed of gelatin
solutions mixed with the non-labeled or labeled MSCs suspended
in cell culture medium at four different concentrations of cells
(2610
3 cells/mL, 1610
4 cells/mL, 5610
4 cells/mL, and 2610
5
cells/mL). A gelatin solution with the same concentration of
gelatin and silica particles as the bottom layer was used to cover
the inclusions after solidification. The absorbance spectrums of all
cell solutions in the eight inclusions were measured using a UV-vis
spectrophotometer. The ICP-MS were used to calculate the
concentrations of Au NTs for inclusions with the labeled MSCs
(9.06610
8 Au NTs/mL, 4.53610
9 Au NTs/mL, 2.27610
10 Au
NTs/mL, and 1.13610
11 Au NTs/mL, respectively).
Combined ultrasound and photoacoustic (US/PA)
imaging
Ultrasound and photoacoustic signals were captured using a
20 MHz array transducer with Vevo 2100 ultrasound micro
imaging system (VisualSonics, Inc.) or a 25 MHz single element,
focused transducer (Panametrics, Inc.) with a data acquisition
board in a computer (CS8500, Gage Applied Technologies, Inc.).
A tunable OPO laser beam (Premiscan, GWU, Inc.) pumped by a
pulsed Nd:YAG laser (Quanta-Ray, Spectra Physics, Inc.) was
delivered through an optical fiber bundle (Ceramoptec, Inc.). The
fiber bundle was combined with the ultrasound transducer and
aligned such that the transmitted light would focus at the focal
point of the transducer. The trigger signal from the laser system
was synchronized with the computer or the Vevo 2100 imaging
system to capture the photoacoustic signal when the pulsed laser
irradiated. Once the photoacoustic transient and ultrasound pulse-
echo signal was captured, the off-line image processing was
performed with the acquired imaging data. The ultrasound and
photoacoustic signals were bandpass filtered (5–45 MHz) to
reduce noise. The magnitudes of the ultrasound and photoacoustic
signals were calculated by taking the absolute values of analytic
signals obtained using the Hilbert transform. The photoacoustic
signal magnitude was then compensated for wavelength dependent
laser fluence. The compensated ultrasound and photoacoustic
signals were interpolated to 2D images. The combined ultrasound
and photoacoustic images were created by overlaying photo-
acoustic intensities higher than a user-defined threshold on the
grayscale ultrasound images.
Supporting Information
Figure S1 Optical selectivity of photoacoustic imaging
for spectral analysis. (A) The normalized absorbance spectra
of Au NTs (top) and the Au NT labeled MSCs (middle). The green
shaded region shows the optical window in biological tissue, which
is the optimal wavelength ranges for in vivo imaging. Comparison
within the optical window of the normalized absorbance spectra of
labeled MSCs, oxygenated and deoxygenated hemoglobin (bot-
tom). (B) Photoacoustic signal amplitude from the inclusions with
5,000 MSCs at multiple wavelengths (532, 600, 650, 700, 750, and
800 nm).
(TIFF)
Figure S2 Cell viability after laser irradiation. Diagram
of the experimental setup for laser irradiation (left) and fluorescent
images of LIVE/DEAD stained MSCs loaded with nanotracers
(right). MSCs were irradiated with 50 laser pulses at 532 nm
wavelength. Cells remain viable after irradiation at laser fluencies
reaching 17 mJ/cm
2, but cell death was observed for laser fluence
higher than 26 mJ/cm
2.
(TIFF)
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